March 21, 2007 – GE Healthcare announced today that because of its Discovery PET/CT business, the company continues to maintain industry leadership during an era of slowed PET market growth, by increasing market share by over 5 percent to exceed 50 percent of the global market.
GE’s Discovery PET/CT system combines positron emission tomography (PET) and computed tomography (CT) in a single, mildly invasive exam to provide physicians with both metabolic and anatomic information to assist in the detection, diagnosis, treatment planning and monitoring of cancer.
July 02, 2024 
